Wednesday, April 02, 2014 10:28:52 PM
I believe Gerald's blog post was to inform us that PhenoGuard is another asset that has great value to outside interests, not necessarily that a partnership would be inked soon. The company already has enough irons in the fire at present, it wouldn't surprise me if PhenoGuard is classified as a medium-term asset and will be moved to near-term after more milestones are achieved on some of the more critical assets, like LymPro and Eltoprazine.
That doesn't mean I'm not excited about the possibilities of PhenoGuard as a revenue-generating machine, especially if we get up-front license fees and royalties on any discovery that leads to revenues. Hopefully we won't have to wait another 5 months to hear something on any progress.
Just my thoughts. Exciting times ahead, but not for those who watch the share price daily like a hawk. It will make one age prematurely.
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM